Evidence map›Paper›PMID 29199028›Full record

ArticlePhysiology & behavior2018

Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.

H H Doyle, A Z Murphy

Abstract read
In one paragraph

Article in Physiology & behavior, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Reversal of morphine-induced respiratory depression with the µAmerican journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  3. Interactive effects of morphine and the HIV integrase inhibitor, cabotegravir, in male and female mice.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
    Article
  4. Article
  5. Article
  6. Pain mechanisms in the transgender individual: a review.Frontiers in pain research (Lausanne, Switzerland) · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Morphine-3-Glucuronide, Physiology and Behavior.Frontiers in molecular neuroscience · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

H H DoyleNeuroscience Institute, Georgia State University, Atlanta, GA 30303, United States.
A Z MurphyNeuroscience Institute, Georgia State University, Atlanta, GA 30303, United States. Electronic address: amurphy@gsu.edu.
Georgia State University · US

Funding

Impact of advanced age on opiate analgesiaR01DA041529 · NIDA · GEORGIA STATE UNIVERSITY · PI MURPHY, ANNE Z · 2017 to 2021
$1.8M
Sex Differences in Opioid AnalgesiaR01DA016272 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI MURPHY, ANNE Z · 2002 to 2006
$1.5M
NIDA NIH HHS R01 DA016272NIDA NIH HHS R01 DA041529
6 · The paper itself

Abstract

Preclinical studies report that the effective dose for morphine is approximately 2-fold higher in females than males. Following systemic administration, morphine is metabolized via Phase II glucuronidation in the liver and brain into two active metabolites: morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G), each possessing distinct pharmacological profiles. M6G binds to μ opioid receptors and acts as a potent analgesic. In contrast, M3G binds to toll-like receptor 4 (TLR4), initiating a neuroinflammatory response that directly opposes the analgesic effects of morphine and M6G. M3G serum concentrations are 2-fold higher in females than males, however, sex-specific effects of morphine metabolites on analgesia and glial activation in vivo remain unknown. The present studies test the hypothesis that increased M3G, and subsequent TLR4-mediated activation of glia, is a primary mechanism driving the attenuated response to morphine in females. We demonstrate that intra-PAG M6G results in a greater analgesic response in females than morphine alone. M6G analgesia was reversed with co-administration of (-)-naloxone, but not (+)-naloxone, suggesting that this effect is μ opioid receptor mediated. In contrast, intra-PAG administration of M3G significantly attenuated the analgesic effects of systemic morphine in males only, increasing the 50% effective dose of morphine two-fold (5.0 vs 10.3mg/kg) and eliminating the previously observed sex difference. An increase in IL-1β, IL-6 and TNF was observed in females following intra-PAG morphine or M6G. In males, only IL-1β levels increased following morphine. Changes in cytokine levels following M3G were limited to TNF in females. Together, these data implicate sex differences in morphine metabolism, specifically M3G, as a contributing factor in the attenuated response to morphine observed in females.

Indexed as

Sex CharacteristicsAnalgesics, OpioidAnimalsCytokinesDose-Response Relationship, DrugFemaleMaleMorphineMorphine DerivativesNaloxoneNarcotic AntagonistsNociceptionPain ThresholdPeriaqueductal GrayRatsRats, Sprague-DawleyAnalgesics, OpioidCytokinesMorphinemorphine-3-glucuronidemorphine-6-glucuronideMorphine DerivativesNaloxoneNarcotic AntagonistsRNA, MessengerTLR4 protein, humanToll-Like Receptor 4AnalgesiaGlucuronideM3GM6GPeriaqueductal graySex differences

Identifiers

PMID29199028
PMCPMC6242342
OpenAlexW2772042003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.